These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25975839)

  • 21. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
    Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
    Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
    La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
    Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential association of CMV-specific CD8+ T lymphocyte reconstitution with the risk of CMV reactivation and persistency in post allogeneic stem cell transplant patients.
    Shams El-Din AA; El-Desoukey NA; Amin Tawadrous DG; Fouad NMBE; Abdel-Mooti M; Hotar SF
    Hematology; 2018 Sep; 23(8):463-469. PubMed ID: 29313439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation.
    Cwynarski K; Ainsworth J; Cobbold M; Wagner S; Mahendra P; Apperley J; Goldman J; Craddock C; Moss PA
    Blood; 2001 Mar; 97(5):1232-40. PubMed ID: 11222365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation.
    Velaga S; Ukena SN; Höpting M; Ivanyi P; Borchers S; Mischak-Weissinger EM; Hamwi I; Buchholz S; Ganser A; Franzke A
    Immunol Invest; 2013; 42(1):18-35. PubMed ID: 23083129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation.
    Gondo H; Himeji D; Kamezaki K; Numata A; Tanimoto T; Takase K; Aoki K; Henzan H; Nagafuji K; Miyamoto T; Ishikawa F; Shimoda K; Inaba S; Tsukamoto H; Horiuchi T; Nakashima H; Otsuka T; Kato K; Kuroiwa M; Higuchi M; Shibuya T; Kamimura T; Kuzushima K; Tsurumi T; Kanda Y; Harada M
    Int J Hematol; 2004 Dec; 80(5):441-8. PubMed ID: 15646657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive but not seronegative donors.
    Hoegh-Petersen M; Roa L; Liu Y; Zhou F; Ugarte-Torres A; Louie P; Fonseca K; Khan F; Russell JA; Storek J
    Cytotherapy; 2012 Feb; 14(2):194-204. PubMed ID: 22149135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.
    Ventura C; Bisceglia H; Girerd-Chambaz Y; Burdin N; Chaux P
    J Clin Immunol; 2012 Dec; 32(6):1305-16. PubMed ID: 22797815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CMV Status Drives Distinct Trajectories of CD4+ T Cell Differentiation.
    Zhang W; Morris AB; Peek EV; Karadkhele G; Robertson JM; Kissick HT; Larsen CP
    Front Immunol; 2021; 12():620386. PubMed ID: 33936035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.
    Cecconi V; Moro M; Del Mare S; Dellabona P; Casorati G
    Cytometry A; 2008 Nov; 73(11):1010-8. PubMed ID: 18612991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets.
    Hassouneh F; Lopez-Sejas N; Campos C; Sanchez-Correa B; Tarazona R; Pera A; Solana R
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation.
    Mendes AV; Benard G; Pereira CB; Kallas EG; Duarte AJ; Pannuti CS; Dulley FL; Machado CM
    Acta Haematol; 2002; 107(4):187-94. PubMed ID: 12053145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation.
    Moins-Teisserenc H; Busson M; Scieux C; Bajzik V; Cayuela JM; Clave E; de Latour RP; Agbalika F; Ribaud P; Robin M; Rocha V; Gluckman E; Charron D; Socié G; Toubert A
    J Infect Dis; 2008 Sep; 198(6):818-26. PubMed ID: 18666855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
    Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy.
    Trivedi D; Williams RY; O'Reilly RJ; Koehne G
    Blood; 2005 Apr; 105(7):2793-801. PubMed ID: 15514011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation.
    Ogonek J; Verma K; Schultze-Florey C; Varanasi P; Luther S; Schweier P; Kühnau W; Göhring G; Dammann E; Stadler M; Ganser A; Koehl U; Koenecke C; Weissinger EM; Hambach L
    J Immunol; 2017 Jul; 199(2):792-805. PubMed ID: 28630092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation.
    Avetisyan G; Larsson K; Aschan J; Nilsson C; Hassan M; Ljungman P
    Bone Marrow Transplant; 2006 Nov; 38(10):687-92. PubMed ID: 17001346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivation.
    Liu J; Chang YJ; Yan CH; Xu LP; Jiang ZF; Zhang XH; Liu KY; Huang XJ
    J Infect; 2016 Sep; 73(3):261-70. PubMed ID: 27311748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Analysis of Early CD4
    Leserer S; Arrieta-Bolaños E; Buttkereit U; Beelen DW; Turki AT
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab.
    Lamba R; Carrum G; Myers GD; Bollard CM; Krance RA; Heslop HE; Brenner MK; Popat U
    Bone Marrow Transplant; 2005 Nov; 36(9):797-802. PubMed ID: 16151431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.